Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycaemic control

AI Summary

Research indicates that Metformin, commonly used for diabetes management, inhibits mitochondrial complex I in the intestinal epithelium, which can enhance glycemic control. This finding may have implications for future therapeutic applications of Metformin in metabolic diseases.